Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Rhythm Pharmaceuticals
RYTM
$7.31B
| $68.3M | 0.03% |
1,219,554
+621,432
| +104% | +$34.3M |
|
327
Walmart Inc
WMT
$909B
| $68M | 0.03% |
752,624
+111,513
| +17% | +$9.68M |
|
328
Federal Realty Investment Trust
FRT
$10.9B
| $66.7M | 0.03% |
595,416
-15,670
| -3% | -$1.77M |
|
329
Constellium
CSTM
$3.76B
| $66.2M | 0.03% |
6,445,290
+292,335
| +5% | +$3.6M |
|
|
EXE
330
Expand Energy Corp
EXE
$22.1B
| $65.9M | 0.03% |
662,381
+48,279
| +8% | +$4.46M |
|
331
Weatherford International
WFRD
$5.9B
| $65M | 0.03% |
907,593
+393,955
| +77% | +$32.3M |
|
332
EastGroup Properties
EGP
$11.2B
| $63.7M | 0.03% |
396,434
+8,462
| +2% | +$1.46M |
|
333
Alcon
ALC
$34B
| $63.4M | 0.03% |
747,664
-88,535
| -11% | -$7.98M |
|
334
Colliers International
CIGI
$5.17B
| $63.4M | 0.03% |
466,425
+5,850
| +1% | +$864K |
|
335
Impinj
PI
$4.25B
| $63.3M | 0.03% |
435,960
+424,851
| +3,824% | +$80.5M |
|
336
UDR
UDR
$12.9B
| $62.3M | 0.03% |
1,435,540
-109,256
| -7% | -$4.83M |
|
337
HDFC Bank
HDB
$123B
| $62.2M | 0.03% |
1,947,958
-5,588
| -0.3% | -$179K |
|
338
Ciena
CIEN
$46.8B
| $61.9M | 0.03% |
729,722
+661,630
| +972% | +$47.5M |
|
339
NRG Energy
NRG
$26.2B
| $61.8M | 0.03% |
685,359
+16,383
| +2% | +$1.52M |
|
340
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $61.4M | 0.03% |
1,393,587
-33,907
| -2% | -$1.58M |
|
341
Clarivate
CLVT
$1.37B
| $60.9M | 0.03% |
11,978,592
-587,147
| -5% | -$3.38M |
|
342
Sabra Healthcare REIT
SBRA
$5.56B
| $60.7M | 0.03% |
3,504,809
+657,950
| +23% | +$12M |
|
343
Williams-Sonoma
WSM
$27.5B
| $60.6M | 0.03% |
327,421
+5,172
| +2% | +$821K |
|
344
Snowflake
SNOW
$98.1B
| $60.2M | 0.03% |
389,756
+364,525
| +1,445% | +$51.3M |
|
345
Vanguard Small-Cap ETF
VB
$78.9B
| $60.1M | 0.03% |
250,094
-106,980
| -30% | -$26.3M |
|
346
Kinsale Capital Group
KNSL
$8.59B
| $59.9M | 0.03% |
128,830
+36,978
| +40% | +$17.5M |
|
|
MREO
347
Mereo BioPharma
MREO
$49.1M
| $59.8M | 0.03% |
17,122,563
+4,776,697
| +39% | +$18.8M |
|
348
UBS Group
UBS
$170B
| $59.7M | 0.03% |
1,951,232
-115,617
| -6% | -$3.66M |
|
349
Roper Technologies
ROP
$40.4B
| $59.2M | 0.03% |
113,879
-2,065
| -2% | -$1.13M |
|
350
Kirby Corp
KEX
$7.02B
| $58.6M | 0.03% |
554,190
+2,550
| +0.5% | +$307K |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.